The Food and Drug Administration (FDA) has approved onabotulinumtoxin A for adult patients who suffer headaches on 15 or more days per month, lasting more than 4 hours. News, Medscape Medical News, October 2010
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
* Copy This Password *
* Type Or Paste Password Here *